deferasirox has been researched along with alpha-synuclein in 1 studies
| Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 832 | 136 | 572 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, C; Chen, YL; Gascon, JM; Kaya, E; McGown, A; Oliveri, V; Platt, FM; Spencer, J; Vecchio, G; Walker, M | 1 |
1 other study(ies) available for deferasirox and alpha-synuclein
| Article | Year |
|---|---|
Synthesis and Study of Multifunctional Cyclodextrin-Deferasirox Hybrids.
Topics: alpha-Synuclein; Animals; Antioxidants; CHO Cells; Cricetulus; Cyclodextrins; Deferasirox; Hep G2 Cells; Humans; Iron Chelating Agents; Protein Multimerization | 2019 |